"You would expect it to be saleable by now, ineptitude of the previous sales strategy aside. And shareholders both current and prospective should in general be critical of their management and the statements they make lest they be easily led astray."
Pretty harsh words Jim.
I accept that BRN's cash reserves right now are diddley squat, but that in itself makes BrainChip's achievements over the last 12 months all the more remarkable. The fact is BrainChip has emerged as a leading player in AI on a global stage with next to no assets except that it holds 100% of the SNAP IP.
There is no point debating the enormous potential of the likes of CISCO or Safran and all the others.
You can't treat management of this company like you treat a pinyada. And I agree with 9Olives, you cant start using a yardstick to measure the performance of Peter, Louis or the rest, as if they're trying to launch no more than next years model can opener.
- Forums
- ASX - By Stock
- BRN
- Ann: March 2017 Quarterly Update
Ann: March 2017 Quarterly Update, page-65
Featured News
Add BRN (ASX) to my watchlist
(20min delay)
|
|||||
Last
25.5¢ |
Change
-0.010(3.77%) |
Mkt cap ! $502.9M |
Open | High | Low | Value | Volume |
26.0¢ | 26.3¢ | 25.0¢ | $3.204M | 12.57M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 434980 | 25.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
26.0¢ | 697239 | 15 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 427780 | 0.255 |
40 | 1257219 | 0.250 |
26 | 676596 | 0.245 |
30 | 1130364 | 0.240 |
17 | 828643 | 0.235 |
Price($) | Vol. | No. |
---|---|---|
0.260 | 641239 | 13 |
0.265 | 450991 | 16 |
0.270 | 660781 | 17 |
0.275 | 749952 | 15 |
0.280 | 699752 | 16 |
Last trade - 16.10pm 18/11/2024 (20 minute delay) ? |
Featured News
BRN (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
SPONSORED BY The Market Online